local & international
analysis & tools
products & services
Thursday, 30 June 2016
Pacific Edge Limited
NZX : PEB
29 Jun 16 17:00
Pacific Edge is a New Zealand based biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer.
Two products have recently completed successful clinical trials, bladder cancer detection and colorectal cancer prognosis (CRC). The bladder cancer technology Cxbladder® has been released to the market in Australia and New Zealand. CRC is being readied for commercial release. Pipeline products still in development include gastric and endometrial cancers and melanoma.
Cxbladder® is a non-invasive, accurate test that enables the early detection of bladder cancer from a small volume of urine providing general practitioners and urologists with a quick, cost effective and accurate measure of the presence of the cancer and provides urologists with the opportunity to reduce their reliance on the need for invasive tests such as cystoscopy.
The Company is commercialising its products from its new diagnostic laboratory in New Zealand and plans further commercialisation in the US and Europe as a centralised diagnostic service through its own facilities or as a turn-key solution, licensed to selected partners. Pacific Edge has plans for further studies in key markets to engage leading medical and urological opinion leaders who will be vital to success in new markets.
Pacific Edge Limited
Anderson Lloyd Caudwell Dunedin
LINK MARKET SERVICES LIMITED
Pricewaterhouse Coopers Dunedin
NZCDC Settlement System
52 wk High:
52 wk Low:
Pacific Edge Limited
87 St David Street
Logicalis US IDs Five Reasons Outsourced Service Desk Demand Is On The Rise
20:48 | 29/6/16
Business Solutions Magazine
... from cutting-edge technologies in a cost-effective way. The Logicalis Group has annualized revenues of over $1.5B from operations in Europe, North America, Latin America and Asia Pacific and is one of the leading IT and communications solution ...
Darryl Glenn wins Colorado's Republican Senate primary, will take on Michael ...
15:33 | 29/6/16
Denver Business Journal
His support of the Trans-Pacific Partnership trade deal with Asian nations cost him the endorsement of the AFL-CIO this year, but the Sierra Club - the 124-year-old conservation group that is one of the most prominent opponents of the state's oil and ...
No Time to Head for Exits
06:45 | 29/6/16
Today European crude supply and demand have a much smaller effect on the world markets than is exerted by Asia Pacific, for instance.
America Opposes Agressive Chinese Actions in Asia (But Trains with China's ...
05:03 | 29/6/16
The National Interest Online (blog)
The US government is sending mixed signals to American allies in Asia by opposing Chinese territorial encroachment while allowing China to take part in a regional military exercise.
Washington sends allies mixed signals with PLA Navy role in RIMPAC
02:03 | 29/6/16
Five naval vessels from the People's Liberation Army Navy (PLAN) recently met up with US warships in preparation for the latest biennial international naval war games known as Rim of the Pacific, or RIMPAC. The exercise, held every two years, include ...
Pacific Edge Board Changes Announced
11:52 | 2/6/16
2 June 2016 PACIFIC EDGE BOARD CHANGES ANNOUNCED Cancer diagnostics company, Pacific Edge Limited (NZX:PEB), has today announced some changes to its Board, including the ap
Amended PEB FY16 Full Year Results - with full Audit Report
11:06 | 26/5/16
Please find attached the amended Full Year Results which now include the full Audit Report. PEB: FULL YEAR RESULTS TO 31 MARCH 2016 Pacific Edge Reports Another Year of Comm
PEB FY16 Full Year Results
10:07 | 26/5/16
26 May 2016 PEB FULL YEAR RESULTS TO 31 MARCH 2016 Pacific Edge Reports Another Year of Commercial Progress and Growth Cancer diagnostics company Pacific Edge Limited (NZX
SSH Notice - Westpac Banking Corporation
08:31 | 20/5/16
Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To: NZ
PACIFIC EDGE PRESENTS POSITIVE CXBLADDER MONITOR(TM) RESULTS
13:47 | 16/5/16
Results Outperform Currently Available Tests for Monitoring Recurrent Urothelial Carcinoma Abstract Selected for Plenary Session at AUA 2016 DUNEDIN, New Zealand and HERSHEY,
There are currently no comments on this topic.
Be the first person to Add a Comment...
ADD USER TO MY FAVOURITE
Customize your favourite:
Send me an alert when this user publishes new articles.
Add a Comment
You must be a registered user to post a comment:
If you are already registered, please
Add to Watchlist
Add to Portfolio
Add Email Alert
Most Viewed Stories
Don't Be a Brexit Bear; Be a Japanese Yen Bear Instead
NZ dollar takes a breather after Brexit
British Pound crushed again: 5 ways UAE residents can benefit from Brexit
Why the Japanese Yen May Be Headed Lower
Where will the FTSE 100 be at Christmas?
Daily NZX Report
Daily Market Report
Daily Forex Report
Daily Global Report
Advertise Online With Us
Hosted by SPIDER
Limited. All the material on this page has the protection of international copyright. All rights reserved.
NZX Quotes are delayed at least 20 minutes. All information provided "as is" for informational purposes only, not intended for trading purposes or advice.
FinData will not be liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.
By accessing the FinData site, you agree not to redistribute the information found therein.